IDbyDNA

IDbyDNA

A company that develops next-generation sequencing (NGS) metagenomics company developing infectious disease tests. It was founded in 2014 and is located in Salt Late City, Utah.

IDbyDNA is a Salt Lake City-based biotechnology company with a focus on metagenomics technology. The company has developed technologies and a platform that profile micro-organisms and pathogens simultaneously in high volumes. The company has a solution for recognizing particles, pathogens, and other micro-organisms, and they called it Explify Respiratory. The solution applies DNA and RNA sequencing to detect and identify bacterial, viral, fungal, and parasitic pathogens by their unique genome sequences. The company uses this technology to identify common and rare pathogens, especially ones difficult to culture, new strains, and complex co-infections.

COVID-19

Since the outbreak of COVID-19, IDbyDNA has made available their Explify Respiratory test which can detect 2019-nCoV as well as over 900 other pathogens. It has also partnered with Illumina to co-market the technology as well as develop it further for more advanced COVID-19 surveillance methods. IDbyDNA is in contact with and cooperates with public health agencies to ensure a coordinated response to suspected or confirmed cases of COVID-19 in patients. The test is able to adapt to emerging and changing pathogens. Their technology and test is a validated Laboratory Developed Test.

Timeline

January 29, 2020
IDbyDNA raises a $20,000,000 series B round from ARTIS Ventures.
September 8, 2016
IDbyDNA raises a $9,000,000 series A round from ARTIS Ventures.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
IDbyDNA Series A round, September 2016
9,000,000
September 8, 2016
2 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Guochun Liao

Co-Founder, CEO

Mark Yandell

Co-Founder, CSO

Martin Reese

Co-Founder, Chairman

Robert Schlaberg

Co-Founder, CMO

Further reading

Title
Author
Link
Type
Date

IDbyDNA to Advance Platform, Now Including Novel Coronavirus, Expand Commercial Operations

Alex Philippidis

Web

January 29, 2020

Illumina taps IDbyDNA for infectious disease sequencing co-marketing initiative

Conor Hale

Web

March 18, 2020

Novel Wuhan Coronavirus Detectable with IDbyDNA Explify Respiratory Test

Web

January 28, 2020

Documentaries, videos and podcasts

Title
Date
Link

D1 16:15 T1-Charles Chiu, UCSF; Robert Schlaberg, IDbyDNA; Heike Sichtig FDA; and Mickey Kertesz, Karius

February 14, 2017

Companies

Company
CEO
Location
Products/Services

IDbyDNA

Guochun Liao

Sunnyvale, California, United States

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.